Thalassemia Treatment in Delhi-NCR
Thalassemia is an inherited blood disorder that affects haemoglobin production. Treatment may include regular blood transfusions, iron chelation therapy, medicines, and, for eligible patients, bone marrow transplantation. Dr. Sanjeev Kumar Sharma provides specialised thalassemia treatment in Delhi-NCR, including Gurgaon, with care tailored to the patient’s condition and needs.

Thalassemia requires lifelong monitoring and personalised treatment to manage anaemia, prevent iron overload, and reduce complications. For patients with severe thalassemia, regular transfusions and iron chelation form an important part of ongoing care.
In selected cases, a bone marrow transplant may offer a potential long-term cure. With expertise in Haemato-Oncology and Bone Marrow Transplantation, Dr. Sanjeev Kumar Sharma provides comprehensive thalassemia care for patients across Delhi-NCR.
What is Thalassemia?
A thalassemia diagnosis can feel like the ground has shifted beneath you, especially when it involves your child. That fear is completely understandable. But here is what we want you to know first; thalassemia is a condition that can be managed well, and in many cases, cured.
Thalassemia is a hereditary (inherited) blood disorder in which the body does not produce enough healthy haemoglobin, the protein inside red blood cells that carries oxygen throughout the body. Without enough healthy haemoglobin, red blood cells break down faster than usual, causing anaemia (low red blood cell count) and the symptoms that come with it.
The condition is caused by mutations (changes) in the genes responsible for haemoglobin production, passed down from parents to children. Globally, around 5% of the world’s population carries a thalassemia gene mutation, making it one of the most common inherited blood disorders. In India alone, an estimated 10,000–12,000 children are born with thalassemia major every year.
How Is Thalassemia Classified?
Thalassemia can be classified in two ways: by the haemoglobin chain affected and by the severity of the condition.
Alpha vs Beta Thalassemia
The type of thalassemia depends on which globin chain of haemoglobin is affected:
| Parameter | Alpha Thalassemia | Beta Thalassemia |
| Affected chain | Alpha-globin chain | Beta-globin chain |
| Cause | Changes in the alpha-globin genes | Changes in the beta-globin genes |
| Severity | Ranges from mild to severe | Ranges from mild to severe |
| Common forms | Silent carrier, trait, HbH disease, hydrops fetalis | Minor, intermedia, major |
| Treatment | Depends on severity; may require transfusions in severe cases | Ranges from no treatment to regular transfusions and iron chelation |
| BMT | Considered in selected severe cases | May offer a potential long-term cure for eligible patients |
Alpha thalassemia affects the alpha-globin chains of haemoglobin, while beta thalassemia affects the beta-globin chains. Both can range from mild to severe, with treatment depending on the type and severity of the condition.
Thalassemia Minor, Intermedia & Major
Thalassemia also exists on a spectrum of severity. This classification helps determine the symptoms, treatment requirements, and level of ongoing care.
| Parameter | Thalassemia Minor | Thalassemia Intermedia | Thalassemia Major |
| Severity | Mild – Carrier state | Moderate | Severe |
| Symptoms | Usually none; mild anaemia | Moderate anaemia, fatigue | Severe anaemia, organ complications |
| Treatment Needed | Usually none | Occasional transfuions, monitoring | Regular transfusions, iron chelation, possible BMT |
| Impact on Daily Life | Minimal – most live completely normal lives | Manageable with periodic care | Significant without treatment; curable with BMT |
Thalassemia minor is usually mild and needs no treatment, but carrier testing is important before family planning. If both parents are carriers, the child has a 25% chance of thalassemia major, 50% chance of being a carrier, and 25% chance of being unaffected. Intermedia may need monitoring and occasional transfusions, while major requires regular transfusions and may be treated with BMT in eligible patients.
Reach Out for Expert Care
Symptoms of Thalassemia
Thalassemia looks very different depending on its type. Knowing the signs and getting the right tests is the critical first step.
Symptoms by Type
Thalassemia minor:
- Often no symptoms at all
- Mild fatigue, especially during physical exertion
- Slightly low haemoglobin on a routine blood test (often mistaken for iron-deficiency anaemia)
Thalassemia major: Symptoms typically appear in the first two years of life:
- Severe fatigue and weakness
- Pale or yellowish skin (jaundice – a yellowing caused by the breakdown of red blood cells)
- Slow growth and delayed development in children
- Enlarged spleen or liver (the organs work overtime to compensate for destroyed red blood cells)
- Bone deformities, particularly in the face and skull
- Dark urine
- Frequent infections
If your child seems unusually tired, is growing slowly, or has a swollen abdomen, please don’t wait. These symptoms warrant a blood test immediately.

How is Thalassemia Diagnosed?
Getting the right diagnosis is straightforward with the correct tests: A simple blood test can help detect thalassemia, while specialised tests can confirm the type and severity.
- CBC (Complete Blood Count): First-line test; checks haemoglobin levels and red blood cell size.
- Haemoglobin electrophoresis: Identifies different haemoglobin types to help confirm thalassemia.
- HPLC: Provides a more precise analysis of haemoglobin and is widely used for thalassemia diagnosis in India.
- Genetic testing: Identifies specific gene mutations and can help with family planning.
- Prenatal diagnosis: CVS or amniocentesis can detect thalassemia in an unborn baby when both parents are carriers.
Early diagnosis is critical. The sooner thalassemia major is identified and treatment begins, the better the long-term outcomes and the lower the risk of organ damage from iron overload.
What are the Thalassemia Treatment Options in Delhi-NCR?
There is no single treatment for thalassemia; the right approach depends on your type, severity, and overall health. Here is what thalassemia treatment in Delhi looks like in practice.
Regular Blood Transfusions
For thalassemia major, regular blood transfusions are the cornerstone of treatment, usually given every 2–4 weeks. They replace healthy red blood cells and help maintain safe haemoglobin levels. Careful blood matching helps reduce reactions and prolongs the life of transfused cells
Iron Chelation Therapy
Repeated transfusions can cause iron overload, allowing excess iron to build up in organs such as the heart and liver. Iron chelation therapy removes this excess iron and helps prevent organ damage.
- Oral chelation: Deferasirox, taken as a daily tablet or dissolved medicine
- Injectable chelation: Deferoxamine, given through slow overnight injections
The choice depends on factors such as iron levels, kidney function, age, and lifestyle.
Folic Acid Supplementation
Folic acid (vitamin B9) supports the production of healthy red blood cells. All thalassemia patients – including those with thalassemia minor – benefit from regular folic acid supplementation, particularly during pregnancy.
Splenectomy (Removal of the Spleen)
If an enlarged spleen starts destroying red blood cells rapidly, surgical removal of the spleen (splenectomy) may be considered. It is not routine and is recommended only when the potential benefits outweigh the risks.
Bone Marrow / Stem Cell Transplant
The only treatment that can potentially cure thalassemia, not just manage it is a bone marrow or stem cell transplant. This is covered in detail in the next section.
Is Thalassemia Curable?: The Role of Bone Marrow Transplant
Yes. Bone marrow transplant (BMT) also called stem cell transplant offers the possibility of a permanent cure for thalassemia major.
Here is how it works in simple terms: the patient’s faulty bone marrow (the factory inside bones that produces blood cells) is replaced with healthy stem cells from a matched donor. These healthy stem cells then begin producing normal haemoglobin on their own permanently. If successful, the patient no longer needs blood transfusions.
Success Rates
With a fully matched sibling donor, BMT for thalassemia can achieve cure rates of 80–90%. Outcomes are generally better in young patients with low iron overload and no significant organ damage.
What If There Is No Matched Sibling?
Not every patient has a matched sibling. In those cases, there are still options:
- Haploidentical transplant – using a half-matched donor, typically a parent. Success rates are lower (around 70–80%) but improving rapidly with newer protocols.
- Unrelated matched donor transplant – using a donor from a bone marrow registry. Outcomes depend heavily on the degree of match.
Dr. Sanjeev Kumar Sharma has experience performing haploidentical BMT for thalassemia, an important option for families without a matched sibling donor. Every case is evaluated individually, and no patient is told there are no options without a thorough discussion.
Why Early BMT Matters?
The earlier BMT is performed, the better the outcomes. Preventing iron overload and related heart, liver, and endocrine damage can improve the chances of a successful cure. For children with thalassemia major, BMT should be considered early rather than as a last resort, but as a planned, hopeful step.
Reach Out for Expert Care
What is the Cost of Thalassemia Treatment in Delhi-NCR?
We know that cost is one of the first things families think about, and we believe in being transparent about it. Thalassemia treatment cost in Delhi-NCR varies based on the treatment, hospital, donor type and individual patient needs. Routine management with transfusions and iron chelation can cost around ₹1.5–3 lakh or more per year, while a bone marrow transplant (BMT) for thalassemia may cost approximately ₹20–35 lakh, depending on the donor type, hospital and treatment requirements.
For BMT cost for thalassemia, key factors include:
- Donor type: Matched sibling, haploidentical or unrelated donor
- Conditioning regimen: Type and duration of chemotherapy
- Hospital stay: Transplant care and post-BMT monitoring
- Insurance: Many policies now cover BMT for thalassemia
- Financial support: Government schemes and NGOs may assist eligible families
Why Choose Dr. Sanjeev Kumar Sharma for Thalassemia Care?
Choosing the right specialist for thalassemia is one of the most important decisions a family can make. Here is why patients from Delhi and across Delhi-NCR, including Gurgaon, Noida, Faridabad, and Ghaziabad, choose Dr. Sanjeev Kumar Sharma.
Dr. Sanjeev Kumar Sharma specialises exclusively in blood disorders and bone marrow transplants, which means every protocol, every decision, and every conversation is grounded in deep, focused expertise.
What sets Dr. Sanjeev Kumar Sharma apart:
- 20+ years of dedicated experience in blood disorders and BMT, not general oncology
- Strong track record with haploidentical BMT for patients without a matched sibling donor
- Treatment tailored to each patient’s thalassemia type, iron burden, and donor availability
- Continuous care from diagnosis and transfusion planning through transplant and recovery
- Close monitoring built around the needs of a lifelong or transplant-cured condition
- Easily accessible Gurugram location, serving Delhi, Faridabad, and Noida
One specialist, guiding your child’s thalassemia journey from diagnosis to life after transplant.
Beyond the Diagnosis: A Plan Built for You
Thalassemia looks different in every patient, and so should its treatment. Dr. Sanjeev Kumar Sharma looks beyond the diagnosis to your specific type, donor availability, and iron burden, then builds a plan around it, from transfusion management to a potential cure through transplant.
The first step is just a conversation. And that conversation could change everything. You don’t have to face thalassemia alone.
Book a consultation to find out what the path ahead looks like for you or your child.
Medical Disclaimer: The information on this page is provided for educational purposes only and should not be used as a substitute for medical advice. Treatment recommendations vary from person to person and should always be based on an individual consultation and clinical evaluation by a qualified healthcare professional.
Frequently Asked Questions
Can thalassemia minor become thalassemia major? expand_more
No. Genetic status is fixed from birth, so minor cannot progress to major. But if two carriers have children together, each child has a 25% chance of thalassemia major which is why genetic counselling before pregnancy matters for carriers.
Can thalassemia be detected before birth? expand_more
Yes. When both parents are carriers, prenatal tests like CVS (10–13 weeks) or amniocentesis (15–20 weeks) can detect whether the baby has thalassemia major, minor, or is unaffected. Carrier couples should seek genetic counselling early in pregnancy
Can a person with thalassemia minor lead a normal life? expand_more
Yes. Thalassemia minor is a carrier state, not a disease, most people live completely normal lives without treatment. The main precaution is getting a partner tested before marriage or pregnancy, since two carriers have a 25% chance of having a child with thalassemia major.
What precautions should thalassemia patients take in daily life? expand_more
A low-iron diet, avoiding iron supplements unless prescribed, staying current on vaccinations, and regular check-ups to monitor heart, liver, and bone health all help prevent complications from iron overload.
How do I book a consultation with Dr. Sanjeev Kumar Sharma? expand_more
To book an appointment with Dr. Sanjeev Kumar Sharma, fill out the appointment form on this website or visit him in person at Paras Health, Gurugram.
Medical Content Grounded in Clinical Expertise
Medical information on this website is developed with a focus on clinical accuracy, current evidence, and patient understanding. Complex topics in haematology, blood disorders, and bone marrow transplantation are presented in clear, accessible language, with medical content carefully researched and reviewed to ensure it remains reliable, relevant, and useful for patients and their families.
